Exencial Wealth Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Exencial Wealth Advisors’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-280	Closed	-$300K	–	392
2020 Q3	$300K	Hold	280	–	–	0.02%	305
2020 Q2	$333K	Buy	+280	New	+$243K	0.03%	256
2020 Q1	–	Sell	-607	Closed	-$699K	–	256
2019 Q4	$699K	Sell	607 -359	-37%	-$322K	0.12%	147
2019 Q3	$597K	Sell	966 -2,797	-74%	-$2.32M	0.13%	136
2019 Q2	$3.78M	Hold	3,763	–	–	0.88%	41
2019 Q1	$4.51M	Sell	3,763 -9	-0.2%	-$9.36K	1.07%	28
2018 Q4	$2.48M	Buy	3,772 +2,973	+372%	+$3.12M	0.67%	55
2018 Q3	$1.49M	Buy	799 +196	+33%	+$385K	0.35%	75
2018 Q2	$1.15M	Sell	603 -109	-15%	-$192K	0.32%	80
2018 Q1	$1.13M	Sell	712 -738	-51%	-$1.37M	0.34%	80
2017 Q4	$2.26M	Buy	1,450 +41	+3%	+$62.8K	0.68%	53
2017 Q3	$2.41M	Buy	+1,409	New	+$1.95M	0.79%	46

Other funds holding LABU

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

HJMC

Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

XSC

X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return

Exencial Wealth Advisors's LABU Position: Q4 2020 in Review

Exencial Wealth Advisors sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2020, closing a stake of 280 shares — an estimated $300K sold.

Exencial Wealth Advisors first reported a position in LABU in Q3 2017 and held it in 12 quarters. The position peaked at $4.51M in Q1 2019. 20 funds tracked by Wall St. Rank hold LABU as of Q4 2020.

Exencial Wealth Advisors reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2020 after selling out during the quarter.
Exencial Wealth Advisors sold 280 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2020, an estimated $300K.
Exencial Wealth Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2017 and held it in 12 quarters.
Exencial Wealth Advisors's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $4.51M in Q1 2019.
20 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2020.

Based on Exencial Wealth Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.